Logo image of BRE.MI

BREMBO N.V. (BRE.MI) Stock Fundamental Analysis

BIT:BRE - Euronext Milan - NL0015001KT6 - Common Stock - Currency: EUR

8.22  +0.02 (+0.24%)

Fundamental Rating

6

Taking everything into account, BRE scores 6 out of 10 in our fundamental rating. BRE was compared to 29 industry peers in the Automobile Components industry. While BRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BRE has a valuation in line with the averages, but on the other hand it scores bad on growth. BRE also has an excellent dividend rating. This makes BRE very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

BRE had positive earnings in the past year.
In the past year BRE had a positive cash flow from operations.
Each year in the past 5 years BRE has been profitable.
Each year in the past 5 years BRE had a positive operating cash flow.
BRE.MI Yearly Net Income VS EBIT VS OCF VS FCFBRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

BRE has a Return On Assets of 8.18%. This is amongst the best in the industry. BRE outperforms 93.10% of its industry peers.
BRE has a Return On Equity of 16.50%. This is amongst the best in the industry. BRE outperforms 93.10% of its industry peers.
With an excellent Return On Invested Capital value of 12.56%, BRE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
BRE had an Average Return On Invested Capital over the past 3 years of 9.44%. This is above the industry average of 6.36%.
The last Return On Invested Capital (12.56%) for BRE is above the 3 year average (9.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.18%
ROE 16.5%
ROIC 12.56%
ROA(3y)6.87%
ROA(5y)6.15%
ROE(3y)13.83%
ROE(5y)12.63%
ROIC(3y)9.44%
ROIC(5y)8.25%
BRE.MI Yearly ROA, ROE, ROICBRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

The Profit Margin of BRE (6.56%) is better than 86.21% of its industry peers.
In the last couple of years the Profit Margin of BRE has declined.
BRE has a Operating Margin of 9.82%. This is amongst the best in the industry. BRE outperforms 93.10% of its industry peers.
In the last couple of years the Operating Margin of BRE has declined.
BRE has a Gross Margin of 54.94%. This is amongst the best in the industry. BRE outperforms 89.66% of its industry peers.
BRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.82%
PM (TTM) 6.56%
GM 54.94%
OM growth 3Y0.2%
OM growth 5Y-3.41%
PM growth 3Y-4.13%
PM growth 5Y-5.19%
GM growth 3Y0.85%
GM growth 5Y0.32%
BRE.MI Yearly Profit, Operating, Gross MarginsBRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

BRE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BRE has less shares outstanding
The number of shares outstanding for BRE has been reduced compared to 5 years ago.
Compared to 1 year ago, BRE has a worse debt to assets ratio.
BRE.MI Yearly Shares OutstandingBRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BRE.MI Yearly Total Debt VS Total AssetsBRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BRE has an Altman-Z score of 3.26. This indicates that BRE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.26, BRE belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
The Debt to FCF ratio of BRE is 85.72, which is on the high side as it means it would take BRE, 85.72 years of fcf income to pay off all of its debts.
BRE has a worse Debt to FCF ratio (85.72) than 79.31% of its industry peers.
BRE has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.43, BRE is doing good in the industry, outperforming 75.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 85.72
Altman-Z 3.26
ROIC/WACC1.76
WACC7.15%
BRE.MI Yearly LT Debt VS Equity VS FCFBRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.55 indicates that BRE should not have too much problems paying its short term obligations.
BRE has a Current ratio of 1.55. This is in the better half of the industry: BRE outperforms 75.86% of its industry peers.
BRE has a Quick Ratio of 1.12. This is a normal value and indicates that BRE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BRE (1.12) is better than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.12
BRE.MI Yearly Current Assets VS Current LiabilitesBRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.53% over the past year.
Looking at the last year, BRE shows a decrease in Revenue. The Revenue has decreased by -0.21% in the last year.
EPS 1Y (TTM)44.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.31%
Revenue 1Y (TTM)-0.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-51.94%

3.2 Future

The Earnings Per Share is expected to grow by 12.41% on average over the next years. This is quite good.
Based on estimates for the next years, BRE will show a small growth in Revenue. The Revenue will grow by 7.69% on average per year.
EPS Next Y30.58%
EPS Next 2Y34.35%
EPS Next 3Y29.69%
EPS Next 5Y12.41%
Revenue Next Year14.97%
Revenue Next 2Y13.14%
Revenue Next 3Y10.93%
Revenue Next 5Y7.69%

3.3 Evolution

BRE.MI Yearly Revenue VS EstimatesBRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
BRE.MI Yearly EPS VS EstimatesBRE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.55, BRE is valued on the expensive side.
BRE's Price/Earnings is on the same level as the industry average.
BRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.88.
Based on the Price/Forward Earnings ratio of 11.50, the valuation of BRE can be described as reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as BRE.
When comparing the Price/Forward Earnings ratio of BRE to the average of the S&P500 Index (21.20), we can say BRE is valued slightly cheaper.
Industry RankSector Rank
PE 20.55
Fwd PE 11.5
BRE.MI Price Earnings VS Forward Price EarningsBRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BRE is cheaper than 65.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRE is valued a bit more expensive than the industry average as 79.31% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 190.06
EV/EBITDA 3.41
BRE.MI Per share dataBRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of BRE may justify a higher PE ratio.
BRE's earnings are expected to grow with 29.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y34.35%
EPS Next 3Y29.69%

7

5. Dividend

5.1 Amount

BRE has a Yearly Dividend Yield of 3.71%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.66, BRE has a dividend in line with its industry peers.
BRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.71%

5.2 History

The dividend of BRE is nicely growing with an annual growth rate of 6.21%!
Dividend Growth(5Y)6.21%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

25.26% of the earnings are spent on dividend by BRE. This is a low number and sustainable payout ratio.
The dividend of BRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.26%
EPS Next 2Y34.35%
EPS Next 3Y29.69%
BRE.MI Yearly Income VS Free CF VS DividendBRE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BRE.MI Dividend Payout.BRE.MI Dividend Payout, showing the Payout Ratio.BRE.MI Dividend Payout.PayoutRetained Earnings

BREMBO N.V.

BIT:BRE (4/30/2025, 7:00:00 PM)

8.22

+0.02 (+0.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-18 2025-03-18/dmh
Earnings (Next)05-08 2025-05-08
Inst Owners20.75%
Inst Owner ChangeN/A
Ins Owners53.61%
Ins Owner ChangeN/A
Market Cap2.74B
Analysts72.86
Price Target9.8 (19.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.71%
Yearly Dividend0.3
Dividend Growth(5Y)6.21%
DP25.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.79%
Min EPS beat(2)-31.9%
Max EPS beat(2)-7.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-3.97%
Max Revenue beat(2)-1.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.73%
PT rev (3m)-14.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.48%
EPS NY rev (3m)-23.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-6.42%
Revenue NY rev (3m)-6.76%
Valuation
Industry RankSector Rank
PE 20.55
Fwd PE 11.5
P/S 0.48
P/FCF 190.06
P/OCF 6.45
P/B 1.2
P/tB 1.38
EV/EBITDA 3.41
EPS(TTM)0.4
EY4.87%
EPS(NY)0.71
Fwd EY8.7%
FCF(TTM)0.04
FCFY0.53%
OCF(TTM)1.27
OCFY15.5%
SpS17.27
BVpS6.87
TBVpS5.94
PEG (NY)0.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.18%
ROE 16.5%
ROCE 18%
ROIC 12.56%
ROICexc 16.86%
ROICexgc 19.22%
OM 9.82%
PM (TTM) 6.56%
GM 54.94%
FCFM 0.25%
ROA(3y)6.87%
ROA(5y)6.15%
ROE(3y)13.83%
ROE(5y)12.63%
ROIC(3y)9.44%
ROIC(5y)8.25%
ROICexc(3y)11.67%
ROICexc(5y)10.3%
ROICexgc(3y)13.3%
ROICexgc(5y)11.77%
ROCE(3y)13.32%
ROCE(5y)11.55%
ROICexcg growth 3Y5.05%
ROICexcg growth 5Y-4.21%
ROICexc growth 3Y5.67%
ROICexc growth 5Y-3.9%
OM growth 3Y0.2%
OM growth 5Y-3.41%
PM growth 3Y-4.13%
PM growth 5Y-5.19%
GM growth 3Y0.85%
GM growth 5Y0.32%
F-Score6
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 85.72
Debt/EBITDA 1.18
Cap/Depr 153.54%
Cap/Sales 7.13%
Interest Coverage 10.73
Cash Conversion 51.01%
Profit Quality 3.81%
Current Ratio 1.55
Quick Ratio 1.12
Altman-Z 3.26
F-Score6
WACC7.15%
ROIC/WACC1.76
Cap/Depr(3y)144.9%
Cap/Depr(5y)127.83%
Cap/Sales(3y)9.75%
Cap/Sales(5y)9.32%
Profit Quality(3y)34.24%
Profit Quality(5y)57.44%
High Growth Momentum
Growth
EPS 1Y (TTM)44.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.31%
EPS Next Y30.58%
EPS Next 2Y34.35%
EPS Next 3Y29.69%
EPS Next 5Y12.41%
Revenue 1Y (TTM)-0.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-51.94%
Revenue Next Year14.97%
Revenue Next 2Y13.14%
Revenue Next 3Y10.93%
Revenue Next 5Y7.69%
EBIT growth 1Y-3.91%
EBIT growth 3Y11.63%
EBIT growth 5Y4.49%
EBIT Next Year67.31%
EBIT Next 3Y25.48%
EBIT Next 5YN/A
FCF growth 1Y-93.9%
FCF growth 3Y-56.19%
FCF growth 5Y-23.42%
OCF growth 1Y-34.48%
OCF growth 3Y0.93%
OCF growth 5Y6.77%